Research Article
HDL-C/apoA-I Ratio Is Associated with the Severity of Coronary Artery Stenosis in Diabetic Patients with Acute Coronary Syndrome
Table 1
Baseline characteristics for non-DM and DM ACS patients.
| Characteristics | Whole () | Non-DM () | DM () | value |
| Age | | | | ns | Male, (%) | 365 (78.00) | 249 (79.30) | 116 (75.32) | ns | BMI (kg/m2) | | | | ns | Current smoker, (%) | 135 (28.8) | 93 (29.62) | 42 (27.27) | ns | Family history of CAD, (%) | 183 (39.10) | 129 (41.08) | 54 (35.06) | ns | Hypertension, (%) | 255 (54.5) | 166 (52.87) | 89 (57.79) | ns | Heart rate (bpm) | | | | ns | Systolic BP (mmHg) | | | | ns | Diastolic BP (mmHg) | | | | ns | LVEF (%) | | | | ns | Affected vessels | | | | <0.05 | BUN | | | | ns | Creatine (μmol/L) | | | | ns | hsCRP (mg/dL) | | | | ns | HDL-C (mmol/L) | | | | ns | LDL-C (mmol/L) | | | | ns | Triglyceride (mmol/L) | | | | ns | Lipoprotein A (mg/L) | | | | ns | apoA-I (g/L) | | | | ns | HbA1c (%) | | | | <0.001 | HDL-C/apoA-I (mmol/g) | | | | <0.01 | Medication at discharge | Aspirin, (%) | 462 (98.7) | 309 (98.4) | 153 (99.4) | ns | Clopidogrel, (%) | 448 (95.7) | 300 (95.5) | 148 (96.1) | ns | Statin, (%) | 459 (98.1) | 309 (98.4) | 150 (97.4) | ns | ACEI/ARB, (%) | 417 (89.1) | 278 (88.5) | 139 (90.3) | ns | Beta-blockers, (%) | 410 (87.6) | 276 (87.9) | 134 (87.0) | ns | CCB, (%) | 102 (21.8) | 68 (21.7) | 34 (22.1) | ns | Main diagnosis | UA | 229 (48.9) | 150 (47.77) | 79 (51.30) | ns | NSTEMI | 71 (15.2) | 50 (15.92) | 21 (13.64) | ns | STEMI | 168 (35.9) | 114 (36.31) | 54 (35.06) | ns |
|
|
Data are and number (%). ACS: acute coronary syndrome; ACEI: angiotensin-converting enzyme inhibitor; apoA-I: apolipoprotein A-I; ARB: angiotensin receptor blocker; BMI: body mass index; BP: blood pressure; BUN: blood urea nitrogen; CAD: coronary artery disease; CCB: calcium channel blocker; CKMB: creatine kinase MB; DM: diabetes mellitus; HbA1c: hemoglobin A1c; HDL-C: high-density lipoprotein cholesterol; hsCRP: high-sensitivity C-reactive protein; LDL-C: low-density lipoprotein cholesterol; LVEF: left ventricular ejection fraction; NSTEMI: non-ST elevated myocardial infarction; STEMI: ST elevated myocardial infarction; UA: unstable angina. |